Lazada Urged to Remove Unregistered E-Cigarettes in Philippines

Mar.16.2023
Lazada Urged to Remove Unregistered E-Cigarettes in Philippines
Lazada urged to remove unregistered e-cigarettes from its platform, similar to Shopee, in compliance with Philippine e-cigarette regulations.

The Philippine E-Cigarette Industry Association (PECIA) and the Philippine Nicotine Consumers Union (NCUP) are urging Lazada to follow in the footsteps of Shopee and remove unregistered e-cigarette products in compliance with the country's Vaporized Nicotine and Non-Nicotine Products Regulation Act (RA 11900), which will take effect on July 25, 2022.


The bill covers electronic cigarette products, e-cigarette juices, e-cigarette devices, heated tobacco products, HTP consumables and devices, and new tobacco products. With the IRR set to take effect on December 28, 2022, all prohibited items under RA 11900 will no longer be sold in online and offline retail markets.


Joey Dulay, the president of PECIA, has stated that Lazada, being one of the most popular online markets, should ensure consumer welfare and protect them from unregistered and substandard products that may cause harm.


The Ministry of Industry has stated unequivocally that Lazada is responsible for complying with e-cigarette-related legislation. Shopee is a platform similar in size to Lazada, and has taken down more than one million unregistered e-cigarette listings from its website. Lazada should also take this issue seriously.


In January of this year, NCUP wrote separate letters to Shopee and Lazada, commending Shopee for taking swift and decisive action against illegal electronic cigarette products, and strongly encouraging Lazada to follow the example set by its competitor.


These platforms have a huge influence on consumers. If they see it on websites, they will think it is safe. Lazada plays a crucial role in preventing the consumption of illegal products. There are now appropriate laws to regulate electronic cigarettes, but if the platform itself does not comply, the law cannot be enforced," said NCUP President Anton Israel in the letter.


On March 1st, representatives from electronic commerce platforms met with the Department of Trade and Industry (DTI) through the Consumer Protection Group (CPG) to address the issue of banned nicotine and non-nicotine vaping products being advertised and sold online despite ongoing monitoring and law enforcement efforts.


On March 1, 2022, the Department of Trade and Industry (DTI) of the Philippines held a meeting with representatives from e-commerce platforms through the Consumer Protection Group (CPG) to address the issue of prohibiting the sale of illegal e-cigarettes online.


One day after the dialogue, Shopee reported that it had removed over one million illegal listings of electronic cigarettes from its platform. It also pledged to strengthen its monitoring of illegal electronic cigarette products and commit to continued cooperation with the trade organization.


Under RA 11900, only electronic cigarette products, devices, and new tobacco products that are registered and certified by the Philippines' Bureau of Standards (BPS) and accompanied by appropriate health warnings can be sold to the public by June 2024.


PECIA is the largest trade organization for electronic cigarettes in the Philippines, with over 200 member shop owners, suppliers, and manufacturers, as well as more than 8,000 E-cigarette alliances, representing over one million smokeless product consumers in the Philippines.


NCUP is a non-profit national advocacy organization that believes the rights and interests of millions of smokers and electronic cigarette users in the Philippines need to be protected from the influence of untested, unregulated, and unregistered products.


Reference:


Lazada has been requested to take down illegal vaping products from its online marketplace.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
The Global State of Tobacco Harm Reduction, a project operated by Knowledge·Action·Change, estimates that about 200 million people worldwide use non-combustible nicotine products including vapes, heated tobacco, nicotine pouches and snus. Its 2026 report says use of these products rose alongside declining smoking rates in 28 countries it analyzed. The data do not establish that all 200 million users have quit smoking, nor do they prove a direct causal relationship. GSTHR also says regulatory restrictions on the products continue to expand in many markets.
Sep.10
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China National Tobacco Corporation and several subsidiaries plan to invest a combined CNY 60 billion ($8.7 billion) in share placements by Industrial and Commercial Bank of China and Agricultural Bank of China as strategic investors. The agreements extend beyond equity investment to corporate governance, banking services and supply-chain finance. The filings also disclose 2025 data on China Tobacco’s tax and profit contributions and industry scale.
Sep.07